Abiopharma

News list

📋 Keating Brendan Joseph (Director) plans to sell 101K shares of BOSTON OMAHA Corp (at $13.68 each, total $1.4M) Filed: Sep 14, 2026 | ID: 006930

Full text

News bot Sept. 14, 2026, 6:33 p.m.
📋 Form 144 Filing: Keating Brendan Joseph

Company: BOSTON OMAHA Corp

Filing Date: 2026-09-14

Relationship: Director
Planned Sale Details:
- Security: Class A
- Shares to be Sold: 100,994
- Price per Share: $13.68
- Total Value: $1,381,597.92
- Planned Sale Date: 2026-09-11
- Broker: Fidelity Brokerage Services LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-38113
- Issuer Contact Phone: 857-256-0079
- Issuer Address: 1601 DODGE STREET, SUITE 3300, OMAHA, NE, 68102
- Broker Address: 245 Summer Street, Boston, MA, 02110
- Shares Outstanding: 29546008.0
- Number of Securities to be Sold: 10
- Remarks: Shares to be sold out of ROSECREST TRUST
- Signature: /s/ Ariadna Gonzalez as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Keating Brendan Joseph